On May 7, 2025, Piper Sandler analyst Jason Bednar reiterated his rating on Masimo (MASI, Financial), maintaining an "Overweight" stance on the stock. The decision reflects continued confidence in the company's performance and prospects in the healthcare technology sector.
However, Bednar also adjusted his price target for Masimo (MASI, Financial) from $215.00 to $200.00 USD. This revision signifies a 6.98% decrease in the previous price target, suggesting a more cautious outlook in the near term.
The updated price target and maintained rating intend to align expectations amidst evolving market conditions and Masimo's operational strategies. Investors in Masimo (MASI, Financial) should consider these analyst insights when evaluating their investment decisions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Masimo Corp (MASI, Financial) is $182.07 with a high estimate of $200.00 and a low estimate of $158.00. The average target implies an upside of 21.80% from the current price of $149.48. More detailed estimate data can be found on the Masimo Corp (MASI) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Masimo Corp's (MASI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Masimo Corp (MASI, Financial) in one year is $127.73, suggesting a downside of 14.55% from the current price of $149.48. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Masimo Corp (MASI) Summary page.
